Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc.
Beijing Biotech
Boehringer Ingelheim
National Institutes of Health Clinical Center (CC)
Centre Oscar Lambret
University of California, San Francisco
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
University of California, San Francisco
University of Florida
Tetragon Biosciences Ltd
University of Florida
NYU Langone Health
Duke University
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Pfizer
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Servier
Servier
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
VA Office of Research and Development
Jonsson Comprehensive Cancer Center
Daiichi Sankyo
City of Hope Medical Center
Massachusetts General Hospital
Pfizer
University of Florida
Columbia University
Weill Medical College of Cornell University
University of Alabama at Birmingham
Neonc Technologies, Inc.
Medical College of Wisconsin
Tcelltech Inc.
NYU Langone Health
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hospices Civils de Lyon